Joshua Dennerlein
Stock Analyst at B of A Securities
(2.16)
# 2,769
Out of 4,884 analysts
95
Total ratings
43.08%
Success rate
-4.55%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $12.48 | -11.86% | 2 | Jun 17, 2025 | |
| SUI Sun Communities | Maintains: Underperform | $124 → $132 | $129.26 | +2.12% | 3 | May 12, 2025 | |
| TRI Thomson Reuters | Reinstates: Neutral | $180 | $201.08 | -10.48% | 1 | Apr 10, 2025 | |
| CTAS Cintas | Reinstates: Buy | $250 | $219.36 | +13.97% | 1 | Apr 10, 2025 | |
| MSCI MSCI Inc. | Initiates: Neutral | $585 | $587.74 | -0.47% | 1 | Apr 10, 2025 | |
| VRSK Verisk Analytics | Reinstates: Underperform | $280 | $304.06 | -7.91% | 1 | Apr 10, 2025 | |
| WELL Welltower | Maintains: Buy | $221 → $242 | $152.77 | +58.41% | 7 | Feb 18, 2025 | |
| GTY Getty Realty | Upgrades: Buy | $31 → $34 | $27.95 | +21.65% | 3 | Oct 21, 2024 | |
| AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $37.07 | -16.37% | 2 | Sep 24, 2024 | |
| NHI National Health Investors | Initiates: Buy | $92 | $70.80 | +29.94% | 1 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $284.20 | +12.95% | 3 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $43.53 | +129.73% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $111 → $147 | $114.01 | +28.94% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $150.47 | +25.61% | 3 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $59.50 | -32.77% | 4 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $18.22 | +37.21% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $36.67 | -15.46% | 11 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $62.93 | -15.78% | 9 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $7.27 | -17.47% | 1 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $40.80 | -19.12% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $17.07 | -12.13% | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $57.68 | -9.85% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.62 | - | 4 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $63.23 | -14.60% | 4 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.38 | +82.65% | 9 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $13.82 | +95.37% | 1 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $16.88 | +98.46% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $32.05 | - | 4 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $71.97 | +8.38% | 2 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $43.51 | +8.02% | 2 | Jan 20, 2022 | |
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $12.48
Upside: -11.86%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $129.26
Upside: +2.12%
Thomson Reuters
Apr 10, 2025
Reinstates: Neutral
Price Target: $180
Current: $201.08
Upside: -10.48%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $219.36
Upside: +13.97%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $587.74
Upside: -0.47%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $304.06
Upside: -7.91%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $152.77
Upside: +58.41%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $27.95
Upside: +21.65%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $37.07
Upside: -16.37%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $70.80
Upside: +29.94%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $284.20
Upside: +12.95%
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $43.53
Upside: +129.73%
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $114.01
Upside: +28.94%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $150.47
Upside: +25.61%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $59.50
Upside: -32.77%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $18.22
Upside: +37.21%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $36.67
Upside: -15.46%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $62.93
Upside: -15.78%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $7.27
Upside: -17.47%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $40.80
Upside: -19.12%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $17.07
Upside: -12.13%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $57.68
Upside: -9.85%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.62
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $63.23
Upside: -14.60%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.38
Upside: +82.65%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $13.82
Upside: +95.37%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $16.88
Upside: +98.46%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.05
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $71.97
Upside: +8.38%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $43.51
Upside: +8.02%